$CELL News
Last published 3y ago
- 3y agoCELLPhenomeX Announces Opto® Memory B Discovery Human Workflow on the Beacon® Optofluidic PlatformPR NewswireEMERYVILLE, Calif., Sept. 27, 2023 /PRNewswire/ -- PhenomeX Inc. (NASDAQ:CELL), a functional cell biology company, announced the Opto® Memory B Discovery Human workflow, further expanding diversity of antibodies
- 3y agoCELLPhenomeX Announces the Release of SpotLight™ Human Lambda Reagent for the Beacon® Platform to Accelerate Cell Line Development WorkflowsPR NewswirePreliminary SpotLight™ Human Lambda reagent data to be showcased by GSK at the 16th annual PEACe Conference EMERYVILLE, Calif., Sept. 21, 2023 /PRNewswire/ -- PhenomeX Inc. (NASDAQ:CELL), a functional cell biology
- 3y agoCELLPhenomeX to Participate in Upcoming Cell Biology ConferencesPR NewswireNew Beacon platform data to be presented by Genovac at Discovery on Target 2023 Poster and podium presentation featuring the Beacon platform to be presented at Annual Festival of Biologics Basel Conference &
- 3y agoCELLPhenomeX Unveils Meteor™ Chips For Quantitative Bulk Analysis On The IsoSpark™ Platform To Revolutionize High Throughput Multiplexed Hands-Free ProteomicsPR NewswireFully quantitative bulk and comprehensive single cell proteomics are now both available on the IsoSpark platform EMERYVILLE, Calif., Sept. 15, 2023 /PRNewswire/ -- PhenomeX Inc. (NASDAQ:CELL), the functional cell
- 3y agoCCFCELLIMNMKLRMoore Kuehn Encourages CELL, CCF, IMNM, and KLR Investors to Contact Law FirmGlobeNewswireNEW YORK, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the
- 3y agoBRKRCELLPhenomeX Inc. Announces Commencement of Cash Tender Offer by BrukerPR NewswireEMERYVILLE, Calif., Sept. 5, 2023 /PRNewswire/ -- PhenomeX Inc. (NASDAQ:CELL) today announced that Bruker Corporation (NASDAQ:BRKR) has commenced, through its wholly owned subsidiary, Bird Mergersub Corporation, a cash
- 3y agoBRKRCELLBruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash TransactionBusiness WireAcquisition initiates Bruker's entry into functional single-cell biology research solutions Bruker Corporation (NASDAQ:BRKR) and PhenomeX Inc. (NASDAQ:CELL) today announced that they have signed a definitive agreement
- 3y agoCELLPhenomeX Reports Second Quarter 2023 Financial Results and Provides Business UpdatePR NewswireStrategic Alternatives Process Continuing; Board Focused on Maximizing Stockholder Value EMERYVILLE, Calif., Aug. 14, 2023 /PRNewswire/ -- PhenomeX, Inc. (NASDAQ:CELL), a life sciences tools company, today reported
- 3y agoCELLPhenomeX to Report Second Quarter 2023 Financial Results on August 14, 2023PR NewswireEMERYVILLE, Calif., Aug. 9, 2023 /PRNewswire/ -- PhenomeX Inc. (NASDAQ:CELL), the functional cell biology company, today announced that the Company will be reporting financial results for the second quarter 2023 after
- 3y agoCELLPhenomeX Announces Lifting of the Stay in AbCellera Patent Infringement CasePR NewswirePhenomeX stands behind its ground-breaking Beacon® technology that advances human health globally; remains confident it will prove its case in court EMERYVILLE, Calif., Aug. 7, 2023 /PRNewswire/ -- PhenomeX Inc.
- 3y agoCELLPhenomeX's Beacon® Technology Enables Early Identification of Potent Omicron-Neutralizing AntibodiesPR NewswireEMERYVILLE, Calif., June 13, 2023 /PRNewswire/ -- PhenomeX Inc. (NASDAQ:CELL), the functional cell biology company, today announced that the Company's technology was recently featured in a groundbreaking study
- 3y agoCELLPhenomeX Launches Beacon Quest™ Optofluidic System with Opto® T Cell Profiling WorkflowsPR NewswireBeacon Quest designed with affordable two-chip optofluidic system to accelerate the pace of scientific discovery across academic, non-profit, and government research including comprehensive single T Cell profiling, for
- 3y agoCELLPhenomeX Launches Beacon Select™ Optofluidic System with Opto® B Discovery WorkflowsPR NewswireAffordable two-chip Beacon Select system to broaden customer access to innovative high throughput, function-first antibody discovery capabilities EMERYVILLE, Calif., May 15, 2023 /PRNewswire/ -- PhenomeX Inc.
- 3y agoCELLPhenomeX Reports First Quarter 2023 Financial ResultsPR NewswireCompany provides full year 2023 financial guidance EMERYVILLE, Calif., May 11, 2023 /PRNewswire/ -- PhenomeX, Inc. (NASDAQ:CELL), a life sciences tools company, today reported financial results for the first quarter
- 3y agoCELLPhenomeX To Participate in 19th Annual PEGS Boston Conference & ExpoPR NewswirePhenomeX optofluidic and proteomic technology to be featured in several poster and podium presentations EMERYVILLE, Calif., May 11, 2023 /PRNewswire/ -- PhenomeX (NASDAQ:CELL), the functional cell biology company, today
- 3y agoCELLPhenomeX to Report First Quarter 2023 Financial Results on May 11, 2023PR NewswireEMERYVILLE, Calif., April 27, 2023 /PRNewswire/ -- PhenomeX Inc. (NASDAQ:CELL), the functional cell biology company, today announced that the Company will be reporting financial results for the first quarter 2023 after
- 3y agoCELLPhenomeX Launches the Opto® T Cell Profiling WorkflowPR NewswireThis workflow revolutionizes immunotherapy research and development by comprehensively profiling single T cells to correlate polyfunctionality with cytotoxicity and recovery of those same cells for downstream
- 3y agoCELLPhenomeX Appoints Peter Silvester to PhenomeX Board of DirectorsPR NewswireEMERYVILLE, Calif., April 10, 2023 /PRNewswire/ -- PhenomeX (NASDAQ:CELL), the functional cell biology company, today announced that Peter Silvester has been named to the PhenomeX board of directors, effective
- 3y agoCELLPhenomeX to Participate in American Association of Cancer Research Annual Meeting 2023PR NewswireEMERYVILLE, Calif., April 7, 2023 /PRNewswire/ -- PhenomeX Inc. (NASDAQ:CELL), the functional cell biology company, today announced its participation at the American Association of Cancer Research (AACR) Annual Meeting
- 3y agoCELLPhenomeX Strengthens Commercial Leadership TeamPR NewswireAppoints Dr. Yan Zhang as Chief Commercial OfficerTomoya Aoyama to Lead Commercial Operations in APAC EMERYVILLE, Calif., March 21, 2023 /PRNewswire/ -- PhenomeX (NASDAQ:CELL), the functional cell biology company, today
- 3y agoBLIISOCELLBerkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology CompanyPR NewswirePhenomeX to begin trading under symbol (NASDAQ:CELL) EMERYVILLE, Calif., March 21, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (NASDAQ:BLI), a life sciences tools company, today announced that it has completed its
- 3y agoBLIISOCELLBerkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology CompanyGlobeNewswireComplementary Technologies, Customer Bases, and Commercial Channels to Strengthen Leadership in High-Growth, Single-Cell Biology Significant Cost Synergies to Increase Profitability and Accelerate Breakeven Horizon in
- 3y agoBLIISOCELLBerkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology CompanyPR NewswireComplementary Technologies, Customer Bases, and Commercial Channels to Strengthen Leadership in High-Growth, Single-Cell Biology Significant Cost Synergies to Increase Profitability and Accelerate Breakeven Horizon in
- 11y agoLXUCCCARJOLN+13LSB Industries and Starboard Value Reach Agreement Regarding Corporate Governance and Board CompositionBusiness WireOKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (NYSE:LXU) (“LSB” or “the Company”), a manufacturer of chemical products for the agricultural, mining and industrial markets and a leading manufacturer of commercial and residential climate control products, today announced that it has elected Louis G. Massimo, Andrew K. Mittag, Richard Roedel, Marran H. Ogilvie and Lynn F. White to its Board of ...
- 14y agoCELLHolzer Holzer & Fistel, LLC Announces Investigation into the Proposed Buyout of BrightPoint, Inc.Business WireATLANTA--(BUSINESS WIRE)--Holzer Holzer & Fistel, LLC is investigating whether the directors of BrightPoint, Inc. (“BrightPoint” or the “Company”) (NASDAQ: CELL) complied with their fiduciary duties in approving the proposed acquisition of the Company by Ingram Micro Inc. According to the Company’s announcement, if the deal closes BrightPoint shareholders will receive $9.00 per share for each shar ...
- 14y agoCELLIMBrightPoint, Inc. (CELL) Is Investigated by Faruqi & Faruqi, LLP for Potential Breaches of Fiduciary DutiesBusiness WireNEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of BrightPoint, Inc. ("BrightPoint" or the “Company”) (NASDAQ: CELL) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Ingram Micro Inc. (NYSE: IM) in an all-cash deal valued at ap ...
- 14y agoCELLLaw Office of Brodsky & Smith, LLC Announces Investigation of Brightpoint, Inc.Business WireBALA CYNWYD, Pa.--(BUSINESS WIRE)--Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Brightpoint, Inc (“Brightpoint” or the “Company”) (Nasdaq: CELL) relating to the proposed acquisition by Ingram Micro, Inc. (“Ingram”).
- 14y agoCELLLaw Offices of Todd M. Garber Announces Investigation of BrightPoint, Inc.Business WireLOS ANGELES--(BUSINESS WIRE)--The Law Offices of Todd M. Garber announces that it is investigating potential claims against the Board of Directors of BrightPoint, Inc. (“BrightPoint” or the “Company”) (NASDAQ: CELL) related to the proposed acquisition of the Company by Ingram Micro Inc. The transaction is valued at approximately $840 million or $9 per share.
- 14y agoCELLRyan & Maniskas, LLP Announces Investigation of BrightPoint Inc.Business WireWAYNE, Pa.--(BUSINESS WIRE)--Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/cell) is investigating potential claims against the board of directors of BrightPoint Inc. (“BrightPoint” or the “Company”) (NASDAQ: CELL) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s efforts to sell BrightPoint to Ingram Micro Inc. in a transaction valued at approxima ...
- 14y agoCELLIMRigrodsky & Long, P.A. Announces Investigation Of Brightpoint, Inc. BuyoutBusiness WireWILMINGTON, Del.--(BUSINESS WIRE)--Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Brightpoint, Inc. (“Brightpoint” or the “Company”) (NASDAQ GS: CELL) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Ingram Micro Inc. (“Ingram”) (NYSE: IM ...
- 15y agoCELLBrightpoint Implements IFS Applications in 15 countriesBusiness WireITASCA, Ill.--(BUSINESS WIRE)--Brightpoint, Inc., (Nasdaq: CELL), one of the world’s leading providers of distribution and supply chain solutions to the wireless industry, has implemented IFS Applications in more than 15 countries in less than two years. The combination of IFS Applications’ component-based flexibility and cost-effectiveness were key factors when Brightpoint selected IFS as the com ...
- 15y agoCELLIntcomex Signs Agreement to Enter into a Strategic Alliance with BrightpointBusiness WireMIAMI--(BUSINESS WIRE)--Intcomex, Inc. a leading IT distributor focused solely on Latin America and the Caribbean today announced that it has signed an agreement to enter into a strategic alliance with Brightpoint, Inc. (Nasdaq: CELL). Under the terms of the agreement, Brightpoint’s wholly-owned Miami-based subsidiary, Brightpoint Latin America, Inc. (“Brightpoint Latin America”), will invest $15 ...